Angiotensin converting enzyme inhibitors – fosinopril

Last updated on October 6, 2022

Special Authority requests can now be submitted online. It's simple and quick!

Generic name	fosinopril
Strength	10 mg, 20 mg
Form	tablet

Special Authority criteria	Approval period
1. Treatment failure on optimal doses of, or intolerance to, ramipril. OR 2. Complex patient requiring medications for co-existing chronic condition(s).	Indefinite

Special Authority criteria

Approval period

1. Treatment failure on optimal doses of, or intolerance to, ramipril.

2. Complex patient requiring medications for co-existing chronic condition(s).

Indefinite

Practitioner exemptions

Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:

Paediatric
Paediatrics Cardiology

Special notes

Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria.

Special Authority request form(s)

Log in to eForms
5328—General Special Authority Request

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Angiotensin converting enzyme inhibitors – fosinopril

Practitioner exemptions

Special notes

Special Authority request form(s)